SoftOx Solutions AS (OB: SOFTX)
Health Care · Pharmaceuticals · NO
Nkr0.09
+3.45% today · -23.7% 1Y
SoftOx Solutions AS (OB: SOFTX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $24.33M.
Over the last twelve months the share price has lost 23.7%, trading between 0.05 and 0.17.
Tweenvest scores SoftOx Solutions AS across four factors: quality 28/100, value 82/100. Its strongest factor is value.
SOFTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.33M
- Revenue (TTM)
- $1.67M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.96
- 52-week high
- Nkr0.17
- 52-week low
- Nkr0.05
- Avg volume (3M)
- —
- Shares outstanding
- 2.60B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.00 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.16 | +0.34% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.18 | -0.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.30 | -1.41% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.00 | -1.14% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.23% |
Figures last refreshed Aug 18, 2026.